Steven R. Johnson

Corporate Officer/Principal en Laureate Biopharmaceutical Services, Inc. .

Consumer Services

Health Technology

Perfil

Steven R.
Johnson is currently the Vice President of Business Development at Laureate Biopharmaceutical Services, Inc. He holds a Master's in Business Administration from James Madison University and an undergraduate degree from the University of Illinois.

Cargos activos de Steven R. Johnson

Empresas	Cargo	Inicio
Laureate Biopharmaceutical Services, Inc. Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ.	Corporate Officer/Principal	29/09/2010

Todos los cargos activos de Steven R. Johnson

Formación de Steven R. Johnson.

University of Illinois	Undergraduate Degree
James Madison University	Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Steven R. Johnson.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Laureate Biopharmaceutical Services, Inc. Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ.	Health Technology